EUVIMEDEUVIMED entdecken
Crossref

Concept of Targeted Drug Conjugate and Its Application in Reversing Drug Resistance

Yuanjiang Wang iD, Wenqing Xu, Bin Zhang, Xinyi Wang, Shaohua Gou iD

Journal of Medicinal Chemistry · 2025

DOI: 10.1021/acs.jmedchem.4c03006 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2025. Verfasst von Yuanjiang Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Pharmaceutical Research Center and School of Chemistry and Chemical Engineering, Southeast University, Nanjing 211189, P. R. China. Hauptthemen laut MEDLINE: Antineoplastic Agents, Drug Resistance, Neoplasm. Die Arbeit nennt 51 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Small-molecule targeted drugs have become the mainstream cancer treatment due to their specific therapy. However, drug resistance inevitably happens to cancer patients. Herein, we propose the "targeted drug conjugate (TDC)" concept to design drugs that enhance antitumor activity, reduce toxicity, and reverse resistance. Upon this idea, compounds Lapa-603 and Lapa-604 were obtained by modifying Pt(II) units with Lapatinib's pharmacophore. Research has found that Lapa-604 can potently inhibit the proliferation of the tested cancer cells and reverse multiple cancer cell resistance by targeting the EGFR protein and causing severe DNA damage. More importantly, Lapa-604 presented higher tumor growth inhibitory efficacy than Lapatinib, Cisplatin, or their physical mixtures in both MDA-MB-231 and BT474 xenograft tumor models. Our research has provided promise for the design and development of novel drugs based on the TDC concept that can effectively overcome drug resistance with stronger antitumor activity and lower toxicity than the corresponding combination therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsDrug Resistance, NeoplasmAnimalsFemaleHumansMiceCell Line, TumorCell ProliferationDNA DamageErbB ReceptorsLapatinibMice, NudeQuinazolinesXenograft Model Antitumor AssaysCisplatin

Substanzen

Antineoplastic AgentsErbB ReceptorsLapatinibQuinazolinesCisplatin

Autor:innen und Institutionen

  • Pharmaceutical Research Center and School of Chemistry and Chemical Engineering, Southeast University, Nanjing 211189, P. R. China.
  • Jiangsu Province Key Laboratory for Biopharmaceuticals and Small Molecule Drugs, Southeast University, Nanjing 211189, P. R. China.

ORCID-Profile: Yuanjiang Wang, Shaohua Gou

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Wang, Y., Xu, W., Zhang, B., Wang, X., & Gou, S. (2025). Concept of Targeted Drug Conjugate and Its Application in Reversing Drug Resistance. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.4c03006

Vancouver

Wang Y, Xu W, Zhang B, Wang X, Gou S. Concept of Targeted Drug Conjugate and Its Application in Reversing Drug Resistance. Journal of Medicinal Chemistry. 2025. doi:10.1021/acs.jmedchem.4c03006

BibTeX
@article{Wang2025,
  author = {Wang, Yuanjiang and Xu, Wenqing and Zhang, Bin and Wang, Xinyi and Gou, Shaohua},
  title = {Concept of Targeted Drug Conjugate and Its Application in Reversing Drug Resistance},
  journal = {Journal of Medicinal Chemistry},
  year = {2025},
  doi = {10.1021/acs.jmedchem.4c03006}
}
Kostenlos starten →